[1]
C. M. Boesjes, “Daily Practice Experience of Baricitinib Treatment for Patients with Difficult-to-Treat Atopic Dermatitis: Results from the BioDay Registry”, Acta Derm Venereol, vol. 102, p. adv00820, Nov. 2022.